Healthcare resource utilization, costs and treatment associated with myasthenia gravis exacerbations among patients with myasthenia gravis in the USA: a retrospective analysis of claims data

Conclusion: Despite utilization of current treatments for MG, MG exacerbations are associated with a high clinical and economic burden in both commercial and Medicare patients. Additional treatment options and improved disease management may help to reduce exacerbations and disease burden.PMID:38099519 | DOI:10.57264/cer-2023-0108
Source: Journal of Comparative Effectiveness Research - Category: General Medicine Authors: Source Type: research